"Stopping Of Covishield Exports Was Huge Problem": Adar Poonawalla

  • 1:29
  • Published On: October 21, 2021
Cinema View
Embed
"The stopping of Covishield exports was a huge problem. Part of the reason I went to the UK was to settle lawsuits and also return part of that funding, reinstating commitment to support them later on in the year," says Adar Poonawalla, CEO of Serum Institute of India on how the suspension of vaccine exports impacted them.

Related Videos

How Has The Serum Institute Ramped Up Export Of Covishield?
November 30, 2021 1:53
1 Of Every 7 Doses Worldwide Administered In India: Dr Balram Bhargava
October 21, 2021 49:51
"Human Lethargy Behind Drop In Vaccine Numbers," Says Adar Poonawalla
October 21, 2021 2:13
"Covishield Exports To Resume Very Soon": Adar Poonawalla
October 21, 2021 1:28
Never Had I Ever Had To Go Through Such Public Scrutiny: Adar Poonawalla
October 21, 2021 1:46
"Is It Fair To Give Boosters Before Other Countries Get First Shot?" Asks Adar Poonawalla
October 21, 2021 1:50
"Next Billion Doses Likely In 3 To 4 Months": Vaccine Panel Head To NDTV
October 21, 2021 3:33
All Adults Should Have First Dose by Year-End: NK Arora To NDTV
October 21, 2021 14:06
Top News Of the Day: Record 100 Crore Covid Jabs Administered In India In Nine Months
October 21, 2021 21:56
Watch: How Vaccines Reached Remotest Parts Of India
October 21, 2021 3:03
100 Crore Jabs: BJP Celebrations In Poll-Bound States To Mark Achievement
October 21, 2021 2:42
Our Offerings: NDTV
  • मध्य प्रदेश
  • राजस्थान
  • इंडिया
  • मराठी
  • 24X7
Choose Your Destination